August 31, 2020 at 5:46 AM EDT
Inside Trump’s stress marketing campaign on federal scientists over a covid-19 therapy
President Trump’s accusatory tweet barreled in at 7:49 a.m. per week in the past Saturday: The “deep state” on the Meals and Drug Administration was making an attempt to sandbag his election prospects by slowing progress on coronavirus therapies and vaccines till after Nov. three.
Shocked and upset, FDA Commissioner Stephen Hahn, who was tagged within the tweet, instantly started calling his contacts on the White Home to search out out why the president was offended. Throughout his conversations, he talked about the FDA was on the verge of granting emergency authorization to convalescent plasma as a therapy for covid-19. The company deliberate to challenge a information launch.
The White Home would upend these plans, turning a preliminary discovering of modest efficacy into one thing a lot greater — a presidential announcement of a “main therapeutic breakthrough on the China Virus,” as White Home press secretary Kayleigh McEnany previewed in a tweet late that Saturday evening.
By Laurie McGinley, Yasmeen Abutaleb, Josh Dawsey and Carolyn Y. Johnson